More than a year has passed since the outbreak of the emergency caused by Coronavirus around the world. A year in which biotechnology has shown an important role in the industry for all to see. With tangible answers to research, know, and then pandemic prevention: from virus sequencing, molecular diagnostics, vaccines, to monoclonal antibody development. But also with concrete proposals for a reconciliation and rebooting the country is likely to be reconciled, for the first time, economically and sustainably developed.
According to OECD estimates, by 2030, biotechnology will have a major role in the world economy: in fact, 80% of pharmaceutical products, 50% of agricultural products, 35% of chemical products. substance and industry will be biotechnology, affecting a total of 2.7%. of global GDP. An industry that proves dynamics: 80% of the biotechnology industry in Italy is made up of small and micro-sized companies, from 2017 to 2019, more than 50 innovative startups operating. in the registered biotechnology sector, 44 other companies just in the first 9 months of 2020.
The requirements of the biotechnology world to the Government are at the heart of ‘Biotechnology, the best future: the importance of the ecosystem to the country’s restart’ organized by Federchimica Assobiotec. organization, a practice that represents 130 companies and technology and science zones operating in Italy.
The economist Lorenzo Bini Smaghi (president of Société Générale), Hon. Angela Ianaro (National Assembly Chair for Health and Science), Luigi Nicolais (Ministry of Universities and Research – PNRR and National Research Development), Elena Sgaravatti (Vice President Federchimica Assobiotec), Anna Lisa Mandorino (Cittadinanzattiva’s secretary general), Pierluigi Paracchi (board member Federchimica Assobiotec – Startup and SME Sector) and Valentino Confalone (CEO Gilead Sciences Italia).
INTRODUCTION RESERVED © Copyright ANSA